Gene: SLC40A1
Official Full Name: solute carrier family 40 member 1provided by HGNC
Gene Summary: The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01604 | SLC40A1 Knockout cell line (HeLa) | Human | SLC40A1 | 1:3~1:6 | Negative | Online Inquiry |
KO01605 | SLC40A1 Knockout cell line (HCT 116) | Human | SLC40A1 | 1:2~1:4 | Negative | Online Inquiry |
KO01606 | SLC40A1 Knockout cell line (HEK293) | Human | SLC40A1 | 1:3~1:6 | Negative | Online Inquiry |
KO01607 | SLC40A1 Knockout cell line (A549) | Human | SLC40A1 | 1:3~1:4 | Negative | Online Inquiry |
SLC40A1 Gene Knockout Cell Lines are specially engineered cellular models that have had the SLC40A1 gene, responsible for iron transport, inactivated through targeted genome editing techniques. This product serves as a critical tool for studying the physiological roles of iron metabolism and the associated pathophysiological conditions, such as hemochromatosis and anemia. By eliminating the expression of the SLC40A1 gene, researchers can directly observe and analyze the downstream effects on cellular iron homeostasis and related signaling pathways.
The primary mechanism by which these knockout cell lines operate revolves around the absence of the SLC40A1 protein, which is essential for iron export from cells into the bloodstream. This absence leads to an accumulation of iron within cells, providing a unique in vitro environment to investigate iron overload disorders or iron-related metabolism. Additionally, the SLC40A1 knockout allows for the assessment of compensatory mechanisms from other iron transporters, facilitating a deeper understanding of systemic iron regulation.
Scientifically, these cell lines hold immense value for researchers focused on iron metabolism, offering insights that can translate into clinical applications for diagnosing and treating disorders linked to iron dysregulation. Their utility extends to drug development, where they can be used to screen therapeutics aimed at modulating iron levels or restoring normal physiological function.
Compared to other models, SLC40A1 Gene Knockout Cell Lines provide a high level of specificity and relevance, thereby enhancing the accuracy of experimental results. The precise targeting of the SLC40A1 gene makes this product a superior choice for those seeking reliable data and reproducibility in their studies.
In summary, SLC40A1 Gene Knockout Cell Lines represent an indispensable resource for researchers and clinicians aiming to unravel the complexities of iron metabolism. With our company's extensive expertise in gene editing technologies and a commitment to advancing scientific discovery, we proudly supply tools that empower innovative research and translational science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.